Pharma & Healthcare Mutual Funds in India specialize in investing in pharmaceutical companies, biotechnology firms, and related healthcare industries.
Long Horizon
20 Funds
₹23,256 Cr Total AUM
Fund name | Fund size | Expense Ratio | 3Y Returns |
---|---|---|---|
DSP Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹2,343 Cr | 0.64% | 17.1% |
Tata India Pharma & Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹893 Cr | 0.84% | 16.9% |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth Sector - Healthcare Very High Risk | ₹3,834 Cr | 1.04% | 16.8% |
SBI Healthcare Opportunities Fund Direct Growth Sector - Healthcare Very High Risk | ₹2,667 Cr | 0.95% | 16.5% |
Mirae Asset Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹2,236 Cr | 0.51% | 15.4% |
Nippon India Pharma Fund Direct Growth Sector - Healthcare Very High Risk | ₹7,132 Cr | 0.92% | 15.1% |
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹699 Cr | 1.02% | 14.8% |
UTI Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹943 Cr | 1.35% | 13.4% |
LIC MF Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹61 Cr | 1.21% | 10.7% |
Identify red flags in your mutual funds and how to fix them
By Market Cap
By Diversification
By Sectors & Themes
By Solutions
Invest in mid-sized companies in their growth phase
Invest in the largest 250 companies in India
Invest in the largest 100 companies in India
Invest in small-sized companies in their growth phase
Tracks a market index
Hybrid funds are a combination of equity and debt investments. The blend of these asset classes varies based on the fund's investment goals.
Debt Mutual Funds invest in fixed-income securities such as government bonds, corporate bonds, treasury bills, and other money market instruments.